CD14 and myeloid sarcoma: We further observed that frequencies of CSF CD14+ myeloid cells were lower in CSF of MS compared to both MOGAD and other ADS patients (Fig. 3C–D), which appeared to reflect elevations in CD14+ myeloid cell counts in the CSF of MOGAD and the other ADS patients, relative to NIND CSF (Fig. 3C, Supplementary Table 2).